PMID: 18304008

Riordan JR
CFTR function and prospects for therapy.
Annu Rev Biochem. 2008;77:701-26., [PubMed]
Sentences
No. Mutations Sentence Comment
418 ABCC7 p.Phe508Ser
X
ABCC7 p.Phe508Ser 18304008:418:74
status: NEW
view ABCC7 p.Phe508Ser details
ABCC7 p.Phe508Ser
X
ABCC7 p.Phe508Ser 18304008:418:102
status: NEW
view ABCC7 p.Phe508Ser details
ABCC7 p.Phe508Arg
X
ABCC7 p.Phe508Arg 18304008:418:83
status: NEW
view ABCC7 p.Phe508Arg details
ABCC7 p.Phe508Arg
X
ABCC7 p.Phe508Arg 18304008:418:111
status: NEW
view ABCC7 p.Phe508Arg details
However, this 710 Riordan was also found to be the case with the isolated domains containing either F508S or F508R substitutions (110). Login to comment
529 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 18304008:529:79
status: NEW
view ABCC7 p.Trp1282* details
This study focused on a single stop mutation common in the Israeli population (W1282X), and the nasal potential difference measurements, all made at a single center, were statistically quite uniform. Login to comment
533 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 18304008:533:49
status: NEW
view ABCC7 p.Trp1282* details
However, effectiveness even in patients with the W1282X mutation alone would represent a highly significant accomplishment if long-term delivery of an appropriate compound, producing clinical benefit without major side effects, can be achieved. Login to comment